Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator

 April 20, 2026

Pharmaphorum

Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI ML in the UK.

OtherRead full story

Post navigation

Update: Lilly makes $7bn bid for in vivo CAR-T firm Kelonia →
← FDA Policy Tracker 2026: Psychedelics get a boost

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com